drugset / Trial / NCT02743949

Comparison of Vonoprazan to Esomeprazole in Participants With Symptomatic GERD Who Responded Partially to a High Dose of Proton Pump Inhibitor (PPI)

NCT02743949

Phase 2 Completed 256 enrolled Takeda
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to determine the effect of vonoprazan compared to esomeprazole for preventing heartburn symptoms over a 4-week treatment period in participants who have a partial response to treatment with esomeprazole.

Timeline

Start
2016-07-14
Primary completion
2018-10-05
Completion
2018-10-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Esomeprazole Small molecule 40 mg Oral
Subject Vonoprazan Other / unclassified 20 mg Oral
Subject Vonoprazan Other / unclassified 40 mg Oral